From the depths of despair in March 2009 when stocks were plumbing multiyear lows, the S&P 500 index SPX, +0.33% has risen like a phoenix to rally roughly 250% in eight years.
Of the 500 stocks that make up the large-cap index, a little over 400 stocks have doubled in value since 2009. Among those, 40 have surged 1,000% or more, meaning that for every $100 invested in any of those shares, the returns today would translate to $1,000 at minimum.
But even those numbers pale when compared with the 10 best-performing stocks in the S&P 500, which have all logged at least a 2,000% surge.
At the top, in a stratosphere of its own, is GGP Inc. GGP, +0.57% a real-estate investment trust, which skyrocketed 7,723% as of Friday. GGP is a prime example of making the podium because it succeeded in digging its way out from rock bottom. GGP, then known as General Growth Properties, traded at record lows, sinking to 25 cents a share on March 6, 2009. before staging its stupendous comeback.
Incyte Corp. INCY, +1.18% a biopharmaceutical company which soared 6,633% in eight years, also made the winner’s circle because its shares had been in free fall before it rebounded.
To some extent, the stock’s success is mirrored by the 412% jump in the Nasdaq Biotechnology Index NBI, +0.68% making the index the second best performer after Nasdaq-100 NDX, +0.41%
Dow Jones Data Group
Many analysts have said this current bull market is, to a large degree, a product of the Federal Reserve’s quantitative easing program in the wake of the 2008 financial crisis. As the Fed prepares to withdraw its support for the market and further tighten monetary policy as early as next week, market watchers are left wondering where the market will be a year from now.
By Sue Chang
No comments:
Post a Comment